Are investors panic selling their shares at medicinal cannabis company Cronos Australia (ASX: CAU)? With 73.4% of the Company’s shares to be released from voluntary escrow soon, it’s the only explanation Cronos could give to the ASX to explain the irregular trading activity. Cronos, who became Australia’s first ever ASX-listed cannabis company to pay out
Read More
Cannabis consumers rejoice, medicinal cannabis provider Cronos Australia (ASX:CAU) is very close to finally releasing its Canview platform to make the procurement of the drug an easy affair. The roll-out is happening across stages with the first one comprising a number of order fulfilment upgrades, process improvements and other efficiencies. It was deployed internally within
Read More
Although it may not be available in Australia for some time due to regulatory restrictions, the newest range of Cronos Australia’s (ASX: CAU) cannabidiol gels to aid high performance are set to hit retail shelves in Hong Kong and Japan. The FCTR range (pronounced Factor) of gels contain pure cannabidiol (CBD) which is mixed with
Read More